Comprehensive Breast Cancer Website

Publication
Article
OncologyONCOLOGY Vol 15 No 5
Volume 15
Issue 5

Breast Cancer On-Line (BCO) at www.bco.org is a multidisciplinary website based in the United Kingdom that may be useful to practicing oncologists, nurses, and scientists working in the field of oncology. The editor-in-chief is John Robertson,

Breast Cancer On-Line (BCO) at www.bco.org is a multidisciplinary website based in the United Kingdom that may be useful to practicingoncologists, nurses, and scientists working in the field of oncology. Theeditor-in-chief is John Robertson, professor of surgery at City Hospital, inNottingham, and the editorial board comprises an international team of prominentphysicians.

Supported by an educational grant from AstraZeneca, BCO iscomprehensive and regularly updated. Among its features are interactive modulesthat contain a number of excellent resources. For example, Journal Club offersrecent articles by both clinicians and scientists, accompanied by criticalreviews. Journal Watch is a monthly update of articles relevant to breast cancercare.

Expert Opinion invites readers to submit clinical cases forexpert comment and reader feedback as well. The Focus On department providestimely, concise, and referenced reviews of current topics (such as pain in thebreast cancer patient) and also invites reader feedback.

Educational Modules

The website’s educational modules include a multiple-chapterNurse Education section dedicated to nurses in cancer care and a fully archivedCase Studies section that allows readers to consider interesting clinical cases.These areas are informative and allow professionals to test their knowledge andreceive quick feedback. Further opportunities for self-assessment are providedin the Visual Library section, a unique array of radiologic and histopathologicimages based on various clinical themes.

Other useful features include a conference calendar and avariety of conference reports, which summarize the major findings presented athalf a dozen major oncology meetings. The report on the Miami Breast CancerConference, for example, contains "quick takes" of major pointsemphasized at the meeting. The Breast Cancer News section contains a year’sworth of highlights.

Links to Other Resources

A larger database can be accessed through the Informationsection. In fact, the reader has access to Medline, Grateful Med, PDQ, and ahost of cancer resources, including several cancer journals, some of whichcontain full text. Lastly, there are numerous links to online cancer sites, bothfor professionals and consumers, with quick access.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.